Best Business Practices And Parting Pearls Of Wisdom On Diversity & Inclusion

Michael McCullar, Ph.D., CEO of OnQuality Pharmaceuticals, an oncology focused drug development company, kicks off this executive virtual roundtable segment by discussing some of the challenges around diversity and inclusion (D&I) during M&A transactions between U.S. startups and non-U.S. based global biopharmaceutical companies. Additional insight on D&I are provided by Pen Lu, M.D., Ph.D., chief medical officer of Pharvaris, a clinical-stage company focused on bringing oral bradykinin B2-receptor antagonists to patients; and Edith Perez, M.D., chief medical officer at Bolt Biotherapeutics, an immuno-oncology company. The full EVR, “Making Diversity & Inclusion A Best Business Practice,” can be viewed here.